THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14

Network Meta-Analysis (NMA)

November 13 from 11:30 am 12:15 pm EST

Innovation Theater, Theater A
Sponsored by Janssen Biotech, Inc.

Network Meta-Analysis, led by two rheumatology experts, will provide an overview of what an NMA is, where it is used, and it will review results of a network meta-analysis evaluation for selective biologic PsA therapies. Data including ACR response and PASI 90 response will be reviewed.

This promotional educational activity is brought to you by Janssen Biotech, Inc. and is not certified for continuing medical education. This is not an official program of the American College of Rheumatology. The consultants are paid speakers for Janssen. The speaker is presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen.

Speakers:

Sergio Schwartzman, MD
Hospital for Special Surgery
Associate Attending Physician
New York, New York

Weill Cornell Medical Center
Clinical Associate Professor Medicine
New York, New York

New York Presbyterian Hospital Associate Attending Physician
New York, New York

Philip Mease, MD, MACR
Swedish Medical Center/Providence-St. Joseph Health
Director of Rheumatology Research
Seattle, Washington

Seattle Rheumatology Associates
Rheumatologist
Seattle, Washington

University of Washington School of Medicine
Clinical Professor
Seattle, Washington

This is not an official program of the American College of Rheumatology.